Trial register facet
Reported trial records — page 27
644 records with the status reported.
Showing 0 records on this page
Records
644 documents · page 27 of 27
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| GNRH-PULSATILE-HH-PKprogramme record | Gonadorelin | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| SERM-DIAGNOSTIC-DDIprogramme record | Sermorelin | Phase 1 | Reported | Randomised crossover | — | — | Very low |
| EPI-RU-ELDERLY-RENAL-IMPprogramme record | Epithalon | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| BPC-PH2-UC-BODY-COMPprogramme record | BPC-157 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| THYMALIN-RU-1-OLEprogramme record | Thymalin | — | Reported | Single-arm open-label | — | — | Very low |
| SEMAX-RU-STROKE-ELDERLYprogramme record | Semax | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| GNRH-DIAGNOSTIC-BODY-COMPprogramme record | Gonadorelin | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| GNRH-PULSATILE-HH-RENAL-IMPprogramme record | Gonadorelin | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| BPC-PH2-UC-QOLprogramme record | BPC-157 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| THYMALIN-RU-1-ADHERENCEprogramme record | Thymalin | — | Reported | Observational | — | — | Very low |
| SEMAX-RU-COGNITIVE-REGIONAL-JPprogramme record | Semax | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SELANK-RU-ANXIETY-RENAL-IMPprogramme record | Selank | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| DSIP-HIST-SLEEP-QOLprogramme record | DSIP | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| GNRH-DIAGNOSTIC-QOLprogramme record | Gonadorelin | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| GNRH-PULSATILE-HH-HEPATIC-IMPprogramme record | Gonadorelin | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| SERM-DIAGNOSTIC-RENAL-IMPprogramme record | Sermorelin | Phase 1 | Reported | Phase 1 ascending dose | — | — | Very low |
| BPC-PH2-UC-REGIONAL-CNprogramme record | BPC-157 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SEMAX-RU-COGNITIVE-BODY-COMPprogramme record | Semax | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| GNRH-PULSATILE-HH-DDIprogramme record | Gonadorelin | Phase 1 | Reported | Randomised crossover | — | — | Very low |
| EPI-RU-ELDERLY-BODY-COMPprogramme record | Epithalon | — | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
page 27 of 27